Mutual Makes Last Plea To High Court For Post-Mensing Case
Mutual Pharmaceutical Co. Inc. stressed Tuesday that if the U.S. Supreme Court did not review a First Circuit ruling over whether generic-drug companies can be targeted for design defect claims, it...To view the full article, register now.
Already a subscriber? Click here to view full article